RxDoctor Payments Data

John Walsh, MD

Emergency Medical Services · Midwest City, OKNPI 1366400137

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by AbbVie at 50.1% of the total. Reporting peaked in 2021 at $142 and has fallen 83.8% since, to $23 in 2025.

$453in general payments, 2019–2025

Across 26 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$227
  • AstraZeneca$144
  • CSL Behring$47
  • W. L. Gore & Associates, Inc.$23
  • Merck$12

What the payments were for

  • Food & beverage$453100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)11$227
AstraZeneca11$144
CSL Behring2$47
W. L. Gore & Associates, Inc.1$23
Merck1$12

How this compares

$453 in reported general payments places this provider in the 75th percentile of 58 emergency medical services providers in Oklahoma.

See all emergency medical services providers in Oklahoma

Medicare billing

Part B allowed, 2024
$114,092
Medicare patients
680
Services billed
783

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate42$1,009
Cephalexin34$353
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$156
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$132
Ondansetron OdtOndansetron15$96
Prednisone38$90
Methocarbamol16$66
Azithromycin18$64

Paid to pharmacies, not to this prescriber.

Other emergency medical services in Midwest City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →